You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-Glutamate Receptor, Ionotropic, AMPA3 (Alpha 3) (GRIA3) Antibodies

L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors.

list all antibodies Gene Name GeneID UniProt
GRIA3 29628 P19492
GRIA3 53623 Q9Z2W9
GRIA3 2913 Q14832
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-Glutamate Receptor, Ionotropic, AMPA3 (Alpha 3) Antibodies at antibodies-online.com

Showing 5 out of 5 products:

Catalog No. Reactivity Host Conjugate Application Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated IC, IF, WB 200 μL Log in to see 9 Days
$487.50
Details
Human Rabbit Un-conjugated WB 100 μL Log in to see 11 to 16 Days
$491.86
Details
Rat Mouse Un-conjugated IC, FACS, IF, WB 100 μg Log in to see 11 to 16 Days
$595.57
Details
Mouse Rabbit Un-conjugated IHC, WB 100 μL Log in to see 7 to 8 Days
$454.67
Details
Human Rabbit Un-conjugated WB 100 μg Log in to see 2 to 3 Days
$378.13
Details

GRIA3 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality
Rat (Rattus)
,
,
Mouse (Murine)


Human

,

More Antibodies against Glutamate Receptor, Ionotropic, AMPA3 (Alpha 3) Interaction Partners

Mouse (Murine) Glutamate Receptor, Ionotropic, AMPA3 (Alpha 3) (GRIA3) interaction partners

  1. These results provide direct evidence for cortical AMPA receptors to contribute to zymosan-induced visceral and spontaneous pain.

  2. Data indicate that the AMPA receptor subunits abundance is hippocampus, GluA2 (show GRIA2 Antibodies) > GluA1 (show GRIA1 Antibodies) > GluA3 >> GluA4 (show GRIA4 Antibodies); cortex, GluA2 (show GRIA2 Antibodies) > GluA3 >/= GluA1 (show GRIA1 Antibodies) >> GluA4 (show GRIA4 Antibodies); and cerebellum, GluA2 (show GRIA2 Antibodies) > GluA3 >/= GluA1 (show GRIA1 Antibodies) > GluA4 (show GRIA4 Antibodies).

  3. This study demonistrated that Gria3 gene expression in mouse dorsal raphe nucleus

  4. This study demonistrated that the GluA3-deficiency in mice is associated with increased social and aggressive behavior and elevated dopamine in striatum.

  5. GluR2 (show GRIA2 Antibodies) and GluR3 subunits of AMPA receptor play roles in the trigeminal nerve injury-mediated enhancement of neuronal excitability and hyperalgesia.

  6. Mice treated with anti-Glur3 antisense peptide nucleic acids had significantly extended survival compared to mice injected with a nonsense sequence in a mouse model of Amyotrophic lateral sclerosis

  7. By the use of two separate cohorts of mice and by means of two different animal models, namely the cue-induced reinstatement and alcohol deprivation effect paradigms, we could show that the GluR-C subunit is involved in alcohol seeking and relapse.

  8. most important property of GluR2 (show GRIA2 Antibodies) in the context of AMPA receptors trafficking may be its influence on calcium permeability

  9. GluR3 subunits have diverse neurophysiological impact, modulating oscillatory networks for sleep, breathing and seizure generation.

  10. MCT2 (show SLC16A7 Antibodies) is linked to AMPA receptor GluR2 (show GRIA2 Antibodies)/3 subunits and undergoes a similar translocation process in neurons upon activation

Human Glutamate Receptor, Ionotropic, AMPA3 (Alpha 3) (GRIA3) interaction partners

  1. Significant association was found between rs12704290 in GRM3 gene and schizophrenia(SCZ). A three-SNP LD spanning GRM3Delta4 splice site was significantly associated with SCZ. Interaction between the LD block and cognitive function was found in SCZ patients.

  2. Results show that GRM3 (show GRM3 Antibodies) rs274622 C carriers with schizophrenia were associated with significantly smaller prefrontal activation than patients with TT genotype

  3. Grm3 (show GRM3 Antibodies) expression was decreased in B cells from patients with autoimmune diseases such as activated systemic lupus erythematosus and multiple sclerosis.

  4. Pharmacogenetic relationships were identified in patients with schizophrenia between GRM3 (show GRM3 Antibodies) variants and symptom response to antipsychotics.

  5. PI4KA (show PI4KA Antibodies) and GRM3 (show GRM3 Antibodies) polymorphisms have potential to jointly modulate antipsychotic response

  6. Findings suggest that mGluR2 (show GRM2 Antibodies)/3 and mGluR5s are unaltered in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia

  7. Results demonstrate no changes in expression and density of both 5-HT2AR and mGlu2 (show GRM2 Antibodies)/3R in the postmortem prefrontal cortex of subjects with major depressive disorder under basal conditions; antidepressant treatment induces a decrease in 5-HT2AR density

  8. The mGluR3 (show GRM3 Antibodies) promoted the proliferation of human embryonic cortical NPCs and increased cyclin D1 (show CCND1 Antibodies) expression by activating ERK1/2 (show MAPK1/3 Antibodies) and JNK2 (show MAPK9 Antibodies) signaling pathways.

  9. The data of this study suggest an association of the GRM3 (show GRM3 Antibodies) rs6465084 polymorphism with changes in pursuit maintenance after antipsychotic treatment.

  10. This study provided that the evidence for an association between GRM3 (show GRM3 Antibodies) genotype and schizophrenia and suggest a role for glutamate (show GRIN1 Antibodies) neurotransmission in the establishment and maintenance of myelinated fibers.

Glutamate Receptor, Ionotropic, AMPA3 (Alpha 3) (GRIA3) Antigen Profile

Protein Summary

L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities.

Gene names and symbols associated with GRIA3

  • glutamate receptor, ionotropic, AMPA 3 (Gria3) antibody
  • glutamate receptor, ionotropic, AMPA3 (alpha 3) (Gria3) antibody
  • glutamate receptor, metabotropic 3 (GRM3) antibody
  • 2900064I19Rik antibody
  • GluA3 antibody
  • Glur-3 antibody
  • GluR-C antibody
  • GluR-K3 antibody
  • Glur3 antibody
  • Gluralpha3 antibody
  • GPRC1C antibody
  • mGlu3 antibody
  • MGLUR3 antibody

Protein level used designations for GRIA3

AMPA-selective glutamate receptor 3 , glutamate receptor 3 , glutamate receptor, ionotrophic, AMPA 3 , glutamate receptor, ionotropic, AMPA3 (alpha 3) , glutamate receptor channel alpha3 subunit , glutamate receptor subunit 3 , glutamate metabotropic receptor 3 , metabotropic glutamate receptor 3

GENE ID SPECIES
29628 Rattus norvegicus
53623 Mus musculus
2913 Homo sapiens
Selected quality suppliers for anti-Glutamate Receptor, Ionotropic, AMPA3 (Alpha 3) (GRIA3) Antibodies
Did you look for something else?